Lunch & Learn: The role of CMC in pharma startups

From concept to clinic: the critical role of CMC in pharma start-ups

Join this interactive session to explore a strategic roadmap for accelerating your development pipeline!

You’ll be equipped with a clear framework and actionable insights to refine your development strategy, tailored to the unique challenges of biotech and pharma innovation. 🧪🧬

• Uncover the critical role of CMC on the route from concept to clinic, and discover how it is integrated with preclinical, clinical, quality, and regulatory functions.
• Dive into real-world case studies to navigate key decision points, risk management, and cross-functional collaboration.
• Gain insights to optimize your path to the clinic, balancing scientific rigor with entrepreneurial agility.

Whether you’re leading a startup or scaling innovation, this session will provide you practical insights and context to help you shape your plans.

Talk by Expert Ethlinn van Gaal of NovoSere

💡Ethlinn van Gaal, PhD in Pharmaceutics, has +10y experience in early-stage pharmaceutical development, specialized in advanced drug delivery, biotechnology, non-biological complex formulations, injectables, pharmaceutics, GMP manufacturing, tech transfer, QbD, project management, and leading development teams. Ethlinn previously worked for Enceladus, Cristal Therapeutics, OctoPlus, Dr. Reddy’s, and Micreos Pharma and co-founded NovoSere in February 2024.

🍃 NovoSere provides a team of experts with deep knowledge and hands-on experience in Chemistry, Manufacturing & Control (CMC). They deliver strategic and operational support, tailored solutions, and expert guidance in CDMO selection and management.

Registration: Free
Walk-in: 11:45
Duration: 12-13h, plus time for questions and discussion
Location: BioPartner Building 1, 21 J.H. Oortweg 2333 CH Leiden